|
인쇄하기
취소
|
Government to raise generic price of innovative drug firms
Published: 2013-01-22 07:00:00
Updated: 2013-01-22 07:00:00
The Ministry of Health and Welfare said Monday that the insurance price of 15 telmisartan generics produced by five innovative drug firms will be raised from today.
Telmisartan is an angiotensin II receptor antagonist used in the management of hypertension. It is marketed under the trade name Micardis (by Boehringer Ingelheim), among others.
The five drug companies are Dong-A Pharm, Chong...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.